|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:GFOD1-CYP39A1 (FusionGDB2 ID:32954) |
Fusion Gene Summary for GFOD1-CYP39A1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GFOD1-CYP39A1 | Fusion gene ID: 32954 | Hgene | Tgene | Gene symbol | GFOD1 | CYP39A1 | Gene ID | 54438 | 51302 |
| Gene name | glucose-fructose oxidoreductase domain containing 1 | cytochrome P450 family 39 subfamily A member 1 | |
| Synonyms | ADG-90|C6orf114 | - | |
| Cytomap | 6p23 | 6p12.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | glucose-fructose oxidoreductase domain-containing protein 1 | 24-hydroxycholesterol 7-alpha-hydroxylasecytochrome P450, family 39, subfamily A, polypeptide 1cytochrome P450, subfamily XXXIX (oxysterol 7 alpha-hydroxylase), polypeptide 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9NXC2 | Q9NYL5 | |
| Ensembl transtripts involved in fusion gene | ENST00000379287, ENST00000603223, ENST00000379278, ENST00000379284, | ENST00000489657, ENST00000275016, | |
| Fusion gene scores | * DoF score | 9 X 3 X 8=216 | 4 X 4 X 4=64 |
| # samples | 9 | 4 | |
| ** MAII score | log2(9/216*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: GFOD1 [Title/Abstract] AND CYP39A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | GFOD1(13486870)-CYP39A1(46607405), # samples:1 GFOD1(13486870)-CYP39A1(46610035), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | GFOD1-CYP39A1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CYP39A1 | GO:0006699 | bile acid biosynthetic process | 10748047 |
| Fusion gene breakpoints across GFOD1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CYP39A1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-AO-A0JG-01A | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| ChimerDB4 | BRCA | TCGA-AO-A0JG-01A | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
Top |
Fusion Gene ORF analysis for GFOD1-CYP39A1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000379287 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| 5CDS-intron | ENST00000379287 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| 5CDS-intron | ENST00000603223 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| 5CDS-intron | ENST00000603223 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| Frame-shift | ENST00000379287 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| Frame-shift | ENST00000603223 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| In-frame | ENST00000379287 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| In-frame | ENST00000603223 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| intron-3CDS | ENST00000379278 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| intron-3CDS | ENST00000379278 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| intron-3CDS | ENST00000379284 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| intron-3CDS | ENST00000379284 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| intron-intron | ENST00000379278 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| intron-intron | ENST00000379278 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| intron-intron | ENST00000379284 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46607405 | - |
| intron-intron | ENST00000379284 | ENST00000489657 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000379287 | GFOD1 | chr6 | 13486870 | - | ENST00000275016 | CYP39A1 | chr6 | 46610035 | - | 2713 | 918 | 945 | 2150 | 401 |
| ENST00000603223 | GFOD1 | chr6 | 13486870 | - | ENST00000275016 | CYP39A1 | chr6 | 46610035 | - | 2820 | 1025 | 1052 | 2257 | 401 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000379287 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - | 0.000504902 | 0.999495 |
| ENST00000603223 | ENST00000275016 | GFOD1 | chr6 | 13486870 | - | CYP39A1 | chr6 | 46610035 | - | 0.000648991 | 0.99935097 |
Top |
Fusion Genomic Features for GFOD1-CYP39A1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for GFOD1-CYP39A1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:13486870/chr6:46607405) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GFOD1 | CYP39A1 |
| FUNCTION: A cytochrome P450 monooxygenase involved in neural cholesterol clearance through bile acid synthesis (PubMed:25201972, PubMed:10748047). Catalyzes 7-alpha hydroxylation of (24S)-hydroxycholesterol, a neural oxysterol that is metabolized to bile acids in the liver (PubMed:25201972, PubMed:10748047). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:25201972, PubMed:10748047). {ECO:0000269|PubMed:10748047, ECO:0000269|PubMed:25201972}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | CYP39A1 | chr6:13486870 | chr6:46610035 | ENST00000275016 | 0 | 12 | 267_287 | 59 | 470.0 | Transmembrane | Helical | |
| Tgene | CYP39A1 | chr6:13486870 | chr6:46610035 | ENST00000275016 | 0 | 12 | 352_372 | 59 | 470.0 | Transmembrane | Helical | |
| Tgene | CYP39A1 | chr6:13486870 | chr6:46610035 | ENST00000275016 | 0 | 12 | 412_432 | 59 | 470.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for GFOD1-CYP39A1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >32954_32954_1_GFOD1-CYP39A1_GFOD1_chr6_13486870_ENST00000379287_CYP39A1_chr6_46610035_ENST00000275016_length(transcript)=2713nt_BP=918nt GAGCGAACATGGCAGCAGAATGAGGAGGCTGGCGCCGGGTCGTGGCCGCCGCTGCCGCGCTGCAGCTCGGGATCCCAGTCCGGCGCGCTC CGGGCCGCATCCTTAGCCGGCCTCCTGGCGGCCGCGGGATTATTTCATTCCCAACGGAGAGCTAGGAAGAAAGGAGACTCCCCCGCGGAG CGGTTCCGTGCTCTGGCAGGGTGTAGACGTTTGTCTGTGCGATTCGCCGGCTGCGCAAACGACGCGGGAGAGAGCCGGTCCCGGGCTGCG GCGGCGCGGCCGCGGGGATGAGCCGGCCATGGAGCGGCCTTGGCGGGGCGCACGCAGCGGACTGGCGCTGCCGCGGGAGCGCAGCCTGAG CCGGGGCTCCAGGGGGCTTCGAAGCCTCCGGCGCCCTGGGGGGGTCCCTGCCGCCGACTCCGGGAAGGACGCGAGCCCCGCGTGGCGGAC ACTGCCGCAGTCACCGTTCTGAGGCGCCCCGAGCTTGCTCCGCCTGCAGCTCGGTGCGCTCTGGGCACCCGGGCGCCTTGCCCGGTGCAC GGCGGCTGGCGCACCGCGGCTAGATTGGCTACAGGAGCGGGGTGCAGGACTGGCTAGAGGTGGGTGTGTGCGCGCGTTGGACTGGAGATC CGAGCAGAAGCAGAACCAGGCGGCTCTGAGCAGCCATGCTTCCCGGGGTGGGCGTGTTCGGCACCAGCCTCACGGCCCGTGTCATCATCC CGCTGCTGAAAGACGAGGGCTTCGCGGTGAAGGCGCTGTGGGGCCGCACGCAGGAAGAAGCGGAGGAGCTGGCCAAGGAGATGAGTGTCC CCTTCTACACTAGCCGCATTGATGAGGTGCTGCTGCATCAGGACGTGGACTTGGTGTGCATTAACCTGCCGCCGCCCCTCACCAGACAGA TCGCTGTCAAAACCCTAGTATGGACCAATATTTACAGTCTTTGCTATGGGAAACCGAATGACCTTTGTTACTGAAGAAGAAGGAATTAAT GTGTTTCTAAAATCCAAAAAAGTAGATTTTGAACTAGCAGTGCAAAATATCGTTTATCGTACAGCATCAATTCCAAAGAATGTCTTTTTA GCACTGCATGAAAAACTCTATATTATGTTGAAAGGGAAAATGGGGACTGTCAATCTCCATCAGTTTACTGGGCAACTGACTGAAGAATTA CATGAACAACTGGAGAATTTAGGCACTCATGGGACAATGGACCTGAACAACTTAGTAAGACATCTCCTTTATCCAGTCACAGTGAATATG CTCTTTAATAAAAGTTTGTTTTCCACAAACAAGAAAAAAATCAAGGAGTTCCATCAGTATTTTCAAGTTTATGATGAAGATTTTGAGTAT GGGTCCCAGTTGCCAGAGTGTCTTCTAAGAAACTGGTCAAAATCCAAAAAGTGGTTCCTGGAACTGTTTGAGAAAAACATTCCAGATATA AAAGCATGTAAATCTGCAAAAGATAATTCCATGACATTATTGCAAGCTACGCTGGATATTGTAGAGACGGAAACAAGTAAGGAAAACTCA CCCAATTATGGGCTCTTACTGCTTTGGGCTTCTCTGTCTAATGCTGTTCCTGTTGCATTTTGGACACTTGCATACGTCCTTTCTCATCCT GATATCCACAAGGCCATTATGGAAGGCATATCTTCTGTGTTTGGCAAAGCAGGCAAAGATAAGATTAAAGTGTCTGAGGATGACCTGGAG AATCTCCTTCTAATTAAATGGTGTGTTTTGGAAACCATTCGTTTAAAAGCTCCTGGTGTCATTACTAGAAAAGTGGTGAAGCCTGTGGAA ATTTTGAATTACATCATTCCTTCTGGTGACTTGTTGATGTTGTCTCCATTTTGGCTGCATAGAAATCCAAAGTATTTTCCTGAGCCTGAA TTGTTCAAACCTGAACGTTGGAAAAAGGCAAATTTAGAGAAGCACTCTTTCTTGGACTGCTTCATGGCATTTGGAAGCGGGAAGTTCCAG TGTCCTGCAAGGTGGTTTGCTCTGTTAGAGGTTCAGATGTGTATTATTTTAATACTTTATAAATATGACTGTAGTCTTCTGGACCCATTA CCCAAACAGAGTTATCTCCATTTGGTGGGTGTCCCCCAGCCGGAAGGGCAATGCCGAATTGAATATAAACAAAGAATATGACATCTGTTG GGCCTCACAAGGACCAGGGCCTTCTGGAGGAGTGGCACTACCCCACCTGGCAGCACCTAGACCTGAGCTCTACAAAAACACACTGCTTCA CTTTGTTTTAGGACTTAGTTCAAGAACACATTCAAATGGTGCATGTGTTTGGTATCTTCAACAGTAGACCAAGAATCTAACATCACTCTC AGTAATATAGAGACCGGAATACATGGTTTATAGGAAATGATCAAATGATCCAAAAAAACTCCACATTTTTTAAGAAGTTGGAATTTGATT TCATGCATAACTGTATTAAAACATTAAATAGAAATAATGTCATTTGAATGAAAATCTTATCACATTAAATTCACTGTGAAGGCAGCATAC TTAAATTTTTATTTTGAAAAGTCTAAAAGGCTTAGATTTTTAAAATTTAATAATTATTTCTACAAATTTTCTATTTTTCTTGAGGTGATT CTCAACTAGCAATTGGAACTCCTAGGCTCTATTAACATAATTCTTTATTGTAAACGTATCTAATGCTAAAAGTAATAAAATGGTAGTTTT >32954_32954_1_GFOD1-CYP39A1_GFOD1_chr6_13486870_ENST00000379287_CYP39A1_chr6_46610035_ENST00000275016_length(amino acids)=401AA_BP= MGNRMTFVTEEEGINVFLKSKKVDFELAVQNIVYRTASIPKNVFLALHEKLYIMLKGKMGTVNLHQFTGQLTEELHEQLENLGTHGTMDL NNLVRHLLYPVTVNMLFNKSLFSTNKKKIKEFHQYFQVYDEDFEYGSQLPECLLRNWSKSKKWFLELFEKNIPDIKACKSAKDNSMTLLQ ATLDIVETETSKENSPNYGLLLLWASLSNAVPVAFWTLAYVLSHPDIHKAIMEGISSVFGKAGKDKIKVSEDDLENLLLIKWCVLETIRL KAPGVITRKVVKPVEILNYIIPSGDLLMLSPFWLHRNPKYFPEPELFKPERWKKANLEKHSFLDCFMAFGSGKFQCPARWFALLEVQMCI -------------------------------------------------------------- >32954_32954_2_GFOD1-CYP39A1_GFOD1_chr6_13486870_ENST00000603223_CYP39A1_chr6_46610035_ENST00000275016_length(transcript)=2820nt_BP=1025nt GCAGGAACACCGGCCGCTGACAGCCAAACTCGCCAACTCCGCCCTCGTCCCCGCGGGATCCCAGAGCCTGAGCCGGCCTGGGGCCGAGGC CGCCCGAGCCGCGAGGCGAGCGAACATGGCAGCAGAATGAGGAGGCTGGCGCCGGGTCGTGGCCGCCGCTGCCGCGCTGCAGCTCGGGAT CCCAGTCCGGCGCGCTCCGGGCCGCATCCTTAGCCGGCCTCCTGGCGGCCGCGGGATTATTTCATTCCCAACGGAGAGCTAGGAAGAAAG GAGACTCCCCCGCGGAGCGGTTCCGTGCTCTGGCAGGGTGTAGACGTTTGTCTGTGCGATTCGCCGGCTGCGCAAACGACGCGGGAGAGA GCCGGTCCCGGGCTGCGGCGGCGCGGCCGCGGGGATGAGCCGGCCATGGAGCGGCCTTGGCGGGGCGCACGCAGCGGACTGGCGCTGCCG CGGGAGCGCAGCCTGAGCCGGGGCTCCAGGGGGCTTCGAAGCCTCCGGCGCCCTGGGGGGGTCCCTGCCGCCGACTCCGGGAAGGACGCG AGCCCCGCGTGGCGGACACTGCCGCAGTCACCGTTCTGAGGCGCCCCGAGCTTGCTCCGCCTGCAGCTCGGTGCGCTCTGGGCACCCGGG CGCCTTGCCCGGTGCACGGCGGCTGGCGCACCGCGGCTAGATTGGCTACAGGAGCGGGGTGCAGGACTGGCTAGAGGTGGGTGTGTGCGC GCGTTGGACTGGAGATCCGAGCAGAAGCAGAACCAGGCGGCTCTGAGCAGCCATGCTTCCCGGGGTGGGCGTGTTCGGCACCAGCCTCAC GGCCCGTGTCATCATCCCGCTGCTGAAAGACGAGGGCTTCGCGGTGAAGGCGCTGTGGGGCCGCACGCAGGAAGAAGCGGAGGAGCTGGC CAAGGAGATGAGTGTCCCCTTCTACACTAGCCGCATTGATGAGGTGCTGCTGCATCAGGACGTGGACTTGGTGTGCATTAACCTGCCGCC GCCCCTCACCAGACAGATCGCTGTCAAAACCCTAGTATGGACCAATATTTACAGTCTTTGCTATGGGAAACCGAATGACCTTTGTTACTG AAGAAGAAGGAATTAATGTGTTTCTAAAATCCAAAAAAGTAGATTTTGAACTAGCAGTGCAAAATATCGTTTATCGTACAGCATCAATTC CAAAGAATGTCTTTTTAGCACTGCATGAAAAACTCTATATTATGTTGAAAGGGAAAATGGGGACTGTCAATCTCCATCAGTTTACTGGGC AACTGACTGAAGAATTACATGAACAACTGGAGAATTTAGGCACTCATGGGACAATGGACCTGAACAACTTAGTAAGACATCTCCTTTATC CAGTCACAGTGAATATGCTCTTTAATAAAAGTTTGTTTTCCACAAACAAGAAAAAAATCAAGGAGTTCCATCAGTATTTTCAAGTTTATG ATGAAGATTTTGAGTATGGGTCCCAGTTGCCAGAGTGTCTTCTAAGAAACTGGTCAAAATCCAAAAAGTGGTTCCTGGAACTGTTTGAGA AAAACATTCCAGATATAAAAGCATGTAAATCTGCAAAAGATAATTCCATGACATTATTGCAAGCTACGCTGGATATTGTAGAGACGGAAA CAAGTAAGGAAAACTCACCCAATTATGGGCTCTTACTGCTTTGGGCTTCTCTGTCTAATGCTGTTCCTGTTGCATTTTGGACACTTGCAT ACGTCCTTTCTCATCCTGATATCCACAAGGCCATTATGGAAGGCATATCTTCTGTGTTTGGCAAAGCAGGCAAAGATAAGATTAAAGTGT CTGAGGATGACCTGGAGAATCTCCTTCTAATTAAATGGTGTGTTTTGGAAACCATTCGTTTAAAAGCTCCTGGTGTCATTACTAGAAAAG TGGTGAAGCCTGTGGAAATTTTGAATTACATCATTCCTTCTGGTGACTTGTTGATGTTGTCTCCATTTTGGCTGCATAGAAATCCAAAGT ATTTTCCTGAGCCTGAATTGTTCAAACCTGAACGTTGGAAAAAGGCAAATTTAGAGAAGCACTCTTTCTTGGACTGCTTCATGGCATTTG GAAGCGGGAAGTTCCAGTGTCCTGCAAGGTGGTTTGCTCTGTTAGAGGTTCAGATGTGTATTATTTTAATACTTTATAAATATGACTGTA GTCTTCTGGACCCATTACCCAAACAGAGTTATCTCCATTTGGTGGGTGTCCCCCAGCCGGAAGGGCAATGCCGAATTGAATATAAACAAA GAATATGACATCTGTTGGGCCTCACAAGGACCAGGGCCTTCTGGAGGAGTGGCACTACCCCACCTGGCAGCACCTAGACCTGAGCTCTAC AAAAACACACTGCTTCACTTTGTTTTAGGACTTAGTTCAAGAACACATTCAAATGGTGCATGTGTTTGGTATCTTCAACAGTAGACCAAG AATCTAACATCACTCTCAGTAATATAGAGACCGGAATACATGGTTTATAGGAAATGATCAAATGATCCAAAAAAACTCCACATTTTTTAA GAAGTTGGAATTTGATTTCATGCATAACTGTATTAAAACATTAAATAGAAATAATGTCATTTGAATGAAAATCTTATCACATTAAATTCA CTGTGAAGGCAGCATACTTAAATTTTTATTTTGAAAAGTCTAAAAGGCTTAGATTTTTAAAATTTAATAATTATTTCTACAAATTTTCTA TTTTTCTTGAGGTGATTCTCAACTAGCAATTGGAACTCCTAGGCTCTATTAACATAATTCTTTATTGTAAACGTATCTAATGCTAAAAGT >32954_32954_2_GFOD1-CYP39A1_GFOD1_chr6_13486870_ENST00000603223_CYP39A1_chr6_46610035_ENST00000275016_length(amino acids)=401AA_BP= MGNRMTFVTEEEGINVFLKSKKVDFELAVQNIVYRTASIPKNVFLALHEKLYIMLKGKMGTVNLHQFTGQLTEELHEQLENLGTHGTMDL NNLVRHLLYPVTVNMLFNKSLFSTNKKKIKEFHQYFQVYDEDFEYGSQLPECLLRNWSKSKKWFLELFEKNIPDIKACKSAKDNSMTLLQ ATLDIVETETSKENSPNYGLLLLWASLSNAVPVAFWTLAYVLSHPDIHKAIMEGISSVFGKAGKDKIKVSEDDLENLLLIKWCVLETIRL KAPGVITRKVVKPVEILNYIIPSGDLLMLSPFWLHRNPKYFPEPELFKPERWKKANLEKHSFLDCFMAFGSGKFQCPARWFALLEVQMCI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for GFOD1-CYP39A1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GFOD1-CYP39A1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for GFOD1-CYP39A1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies